Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we examine once again, Filament Health (FH.NEO), a Canadian company leading the psychedelics sector in natural extraction of psilocybin. Having the first public company patent for its extraction technology, Filament is sitting in the catbird seat within this nascent industry.

Enjoy!